Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice

<b>Background/Objectives:</b> Intranasal vaccination enhances protection against respiratory viruses by providing stimuli to the immune system at the primary site of infection, promoting a balanced and effective response. Influenza vectors with truncated NS1 are a promising vaccine appro...

詳細記述

書誌詳細

出版年:	Vaccines
主要な著者:	Mariia V. Sergeeva, Kirill Vasilev, Ekaterina Romanovskaya-Romanko, Nikita Yolshin, Anastasia Pulkina, Daria Shamakova, Anna-Polina Shurygina, Arman Muzhikyan, Dmitry Lioznov, Marina Stukova
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2024-12-01
主題:	influenza vector mucosal vaccine SARS-CoV-2 inactivated vaccine VAERD
オンライン･アクセス:	https://www.mdpi.com/2076-393X/13/1/15